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A new member of the ras gene family was characterized from Neurospora crassa cDNA libraries. The clone designated N&as codes for a polypep- 
tide containing 213 amino acids (Mr 24000). This polypeptide is 84% homologous to the H-ras-I domain comprising the first 80 amino acids and 
60% homologous to the next 84 residues. The NC-ras polypeptide contains all the well-known sequences involved in the interaction with GTP/GDP, 
the recognition of the Y 13-259 neutralizing antibody, the “effector site’ for interaction with GAP proteins, and the CAAX acylation motif in the 
COOH-terminal. 
Neurospora crassa; ra.r-sequence; cDNA 
1. INTRODUCTION 2.2. cDNA libraries and DNA probes 
Two N~r~~ra crassa cDNA libraries were used. One of them, 
Ras, rho and ypt constitute a superfamily of 
regulator entities in eukaryotes [1,2]. Proto-oncogenic, 
normal, ras genes were described in human, rodent and 
chicken cells [3-71, as well as in Drosophila I&9], Dyc- 
tiostelium discoideum [lo], Saccharomyces cerevisiae 
[I l] and Schizosaccharomyces pombe [12]. With the 
only exception of S. cerevisiae, where ras genes code for 
polypeptides of 40-41 kDa, the others code for 21-24 
kDa polypeptides. 
made in the Xgtl 1 vector and containing inserts of about 300 bp, was 
kindly provided by Dr RajBandhari (Massachusetts Institute of 
Technology). The other, made in the X-ZAP vector (Stratagene Clon- 
ing Systems, San Diego, CA, USA) and containing inserts longer than 
1 kbp, was a gift of Dr M. Sach (Stanford University). Clones harbor- 
ing RASI and RAD2 Saccharomyces cerevisiae sequences were kindly 
provided by Dr M. Wigler (Cold Spring Harbor Laboratory). 
2.3. Preparation of DNA and RNA 
Although the physiological role of ~21-24 ras pro- 
teins has not been elucidated, they seem to be involved 
in the control of cell proliferation and differentiation 
[13] through the interaction with a GTPase activating 
protein (GAP [14]. From a biochemical point of view, 
the ras family is closely related to the G-protein family. 
As occurs with this latter family, ras proteins have been 
shown to bind GTP and GDP, to have a GTPase activi- 
ty and to be associated to the plasma membrane [15,161. 
DNA from Neurospora crassa or from recombinant phages was 
prepared following the procedures of Blin and Stafford [18] and 
Yamamoto [19], respectively. Total Neurospora crassa RNA was ob- 
tained following the method of Reinert et al. [ZO] and poly(A) * RNA 
was purified by oligo(dT)-cellulose chromatography [tl]. 
2.4. Labeling of DNA and hybridization 
DNA probes used for hybridization to DNA and RNA were labeled 
either by nick translation [22] or random priming 1231. 
This paper describes the isolation of Neurosporu 
cDNA clones coding for a protein of the ras family. 
These clones code for a 24 kDa protein containing all 
the characteristic domains of human, rat, Dyc- 
tiosie~ium and ~accharomyc~ ras proteins. 
DNA and RNA blottings were performed accordingly on Gene 
Screen membranes (New England Nuclear). For RNA blotting about 
50 fig of total RNA or 10 pg of poly(A)+ RNA were electrophoresed 
according to Lehrach et al. (241. 
Hybridizations were carried out in the presence of 2x Denhardt 
solution, 100 pg/ml salmonsperm DNA, 1% sodium dodecylsulphate 
(w/v) and 10% dextran sulfate (w/v) at low stringency (Tm - 35: 5 x 
SSC; 30% formamide; 42’C) or high stringency (r, - 5: 0.5 x SSC; 
50% fo~~ide; 42’C). Conditions for washings were 2x SSC, 
0. I % SDS (w/v) and 50°C (%, - 35) or 0.1 x SSC, 0.1% SDS (w/v) 
and 60°C (Tm - 5). 
2. EXPERIMENTAL 
2.1. Strains and media 
2.5. DNA sequencing 
Neurospora crassa wild-type Saint Lawrence 74 was grown in 
Vogel’s liquid minimal medium [17] containing 2% sucrose (w/v) and 
5 ag/ml D-biotin, for 48 h at 30°C with shaking. 
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It was performed by the dideoxy-chain termination method [ZS] 
after subcloning the restriction fragments into the M13mp18 and 
M13mp19 vectors [26]. Sequences were analyzed with the Pustell 
DNA/Protein Sequence Analysis Software (International 
Biotechnologies Inc., New Haven, CT, USA). NC-ras cDNA se- 
quence has the EMBL Data Library accession number X53533 N. 
CRASSA NC-RAS CDNA. 
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-5) to some mRNA species in Northern blots of 
Neurospora poly(A) + RNA. As can be seen in Fig. 1, 
the S. cerevisiae RAS2 IIpaI probe and the insert from 
the selected clone, could detect the presence of an 
mRNA species of about 2.5 kb. The XC33 probe also 
detected a minor component of about 3.4 kb. 
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Fig. I. Northern blots of Neurospora crassa total RNA or poly(A) ’ 
RNA. RNA was hybridized with the 1.2 kbp HpuI restriction frag- 
ment from a Saccharomyces cerevisirre RAS2 clone (Tm - 35) or with 
the 5.53 bp EcoRI restriction fragment from Neurospora crassa XC33 
clone (T’ - 5), respectively. Mobilities of Neurospora 26 S and 17 S 
RNAs are also indicated, as we11 as those of 2.5 and 3.5 kb RNA 
species. 
3. RESULTS AND DISCUSSION 
A Neurospora crassa cDNA library made in the Xgt I 1 
vector was screened at low stringency (T, - 35) with a 
1.2 kbp HpaI restriction fragment from a Sac- 
charomyces cerevisiae RAS2 clone [ 111. From 38 clones 
giving a strong hybridization signal, the clone 
designated XC33 (553 bp) was selected for further 
studies. The crite~um for this selection was the 
capability of the corresponding insert to hybridize (Z%, 
October 1990 
The XC33 cloned insert was used to screen a 
Neurospora crassa cDNA library made in the h-ZAP 
vector known to contain full-length representations of 
some RNAs. From about 70~ screened plaques, a 
clone containing an insert of about 1.9 kbp was 
selected. The insert corresponding to this clone, termed 
NC-ras, and that from XC33 were subcloned and se- 
quenced. Fig. 2 shows a 1115 nucleotide partial se- 
quence corresponding to NC-m and the predicted 
amino acid sequence. XC33 sequence is included into 
NC-rus (residues 180-733). Several elements are evident 
in this sequence: (i) an open-reading frame for a protein 
containing 213 amino acids; (ii) the methionine start 
codon is contained into a consensus Kozak sequence 
(CCACAATGG) for initiation by eukaryotic ribosomes 
1271; (iii) the sequence does not present a consensus 
polyadenylation signal suggesting that the 3 ’ non- 
coding region extends further downstream; and (iv) a 62 
nucleotide long poly(dC-dA) tract is located 78 
nucleotides downstream of the TGA stop codon, within 
the 3 ’ non-coding region. This tract was found in 
several mRNAs [28], including that encoded by the 
BRL-ras-related gene, a member of the mammalian ras 
superfamily 1291 and it seems to be a transcription 
enhancer 1301. 
NC-m codes for a polypeptide containing 213 amino 
acids with calculated molecular weight and isoelectric 
point of 24006.4 and 5.71, respectively. Fig. 3 shows 
721 ocMcAccTcAl-r CGCOWWUT~~T~ WWCW~~W~TAAT@TGTWT~TCW 
GGTSFANNNGAVKQMDVGDEDVQAGCCAKCIMM- 213 
Fig. 2. Nucleotides and predicted amino acid sequences of N~ros~ra erassa NC-ras. Sequence of the XC33 clone corresponds to that between 
nucleotides 180 and 733. Underlined bases indicate positions of San site, Kozak sequence, X&I and Hind111 sites, and the poly(dC-dA) sequence. 
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Fig. 3. Comparison of NC-ras amino acid sequence with those of human/rat H-MS-Z and fur-protein sequences from lower eukaryotic organisms. 
Consensus sequences for the acylation motif, binding of GTP/GDP or of the Y13-259 neutralizing antibody, and the ‘effector site’ for interaction 
with GAP proteins, are indicted (underlined), as well as positions of some amino acids involved in oncogenic transformation (asterisks). 
the alignment of the predicted amino acid sequences 
corresponding to human/rat H-ras-Z proto-oncogenic 
polypeptide and the five known ras sequences from 
lower eukaryotic organisms, including NC-ras. The 
Neurospora crassa ras polypeptide is 84% homologous 
to the H-ras-Z domain comprising the first 80 residues 
and 60% homologous to the next 84 amino acids. In 
this tract of 164 amino acids NC-ras shows the highest 
sequence identity with H-ras-I, compared with the 
reported lower eukaryotic ras sequences. The rest of the 
polypeptide, containing the so-called hypervariable do- 
main, shows scarce homology, except for the CAAX 
acylation motif in the COOH terminal [2]. In this 
motif, the aliphatic amino acids (A) are isoleucine and 
methionine. 
The NC-ras polypeptide contains all the four se- 
quence elements G&GK”/T (amino acids 15-22), 
DX2G (amino acids 62-65), NKXD (amino acids 
121-124) and EXSA (amino acids 149-152) involved in 
the interaction with GTP/GDP [43], the recognition of 
the Y13-259 neutralizing antibody, and the ‘effector 
site’ for interaction with GAP proteins [2,16,17]. All 
these sequences are 93% homologous to their 
equivalents of H-ras-Z. For all these reasons it is evident 
that NC-ras is a new member of the ras-protein family. 
Results reported in this paper show that Neurospora 
crassa NC-ras codes for a 24 kDa polypeptide that 
belongs to the ras family. This polypeptide contains the 
Gly”,Gly , ‘* Ala@ and Gln66 residues which are iden- 
tical to the residues in positions 12,13,59 and 61 of nor- 
mal H-ras-Z protein in humans and mice. Changes in 
these positions lead to the abolition of H-ras-Z GTPase 
activity in the presence of GAP. Taking in considera- 
tion all these results, together with the fact that Sac- 
charomyces cerevisiae RASZ and RAS2 code for pro- 
teins of about 41 kDa, it is evident that Neurospora 
crassa NC-ras and Schizosaccharomyces pombe SPras 
represent he lowest, conserved, evolutive antecedents 
of the ras p21-~24 family in a period of about 800 
million years. 
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